Page last updated: 2024-12-05

n-pentanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-Pentanoic acid, also known as valeric acid, is a naturally occurring fatty acid with a pungent odor. It is found in various plants and animals, including valerian root, which is known for its calming effects. n-Pentanoic acid can be synthesized through various methods, such as the oxidation of pentanol or the fermentation of carbohydrates. Research on n-Pentanoic acid is driven by its potential applications in medicine, agriculture, and food production. It has been studied for its anti-inflammatory, anti-anxiety, and anti-tumor properties, as well as its potential as a biofuel and a flavoring agent in food.'

n-pentanoic acid: RN given refers to unlabeled parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

valeric acid : A straight-chain saturated fatty acid containing five carbon atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7991
CHEMBL ID268736
CHEBI ID17418
SCHEMBL ID5886
MeSH IDM0116541

Synonyms (110)

Synonym
smr000471834
MLS001066335
gtpl1061
CHEBI:17418 ,
ch3-[ch2]3-cooh
pentoic acid
n-bucooh
valeriansaeure
nsc 406833
valeric acid, normal
brn 0969454
ai3-08657
kyselina valerova [czech]
hsdb 5390
fema no. 3101
einecs 203-677-2
SHF ,
1-butanecarboxylic acid
inchi=1/c5h10o2/c1-2-3-4-5(6)7/h2-4h2,1h3,(h,6,7
valeric acid, n-
butanecarboxylic acid
n-pentanoic acid
propylacetic acid
wln: qv4
nsc-406833
nsc406833
valeric acid
pentanoic acid
n-valeric acid
valerianic acid
109-52-4
C00803
n-pentanoate
valeric acid, >=99%, fcc, fg
DB02406
1YLV
LMFA01010005
c5:0
valeric acid, 99%
valeric acid, >=99%
pentanoic acid valeric acid
BMSE000345
CHEMBL268736
butane-1-carboxylic acid
FT-0651620
FT-0694066
V0003
AKOS000118960
NCGC00183281-02
NCGC00183281-01
4-02-00-00868 (beilstein handbook reference)
unii-gzk92pjm7b
kyselina valerova
ec 203-677-2
gzk92pjm7b ,
dtxsid7021655 ,
dtxcid801655
tox21_303030
cas-109-52-4
NCGC00256597-01
tox21_201561
tox21_113414
NCGC00259110-01
HMS2267A03
STL169350
pentanoic acid-1-13c
valeric acid [fcc]
valeric acid [fhfi]
valproic acid impurity a [ep impurity]
pentanoic acid [hsdb]
valeric acid [mart.]
n-valeric acid [mi]
n-valerate
SCHEMBL5886
n-c4h9cooh
1-pentanoic acid
valericacid
64118-37-2
83741-76-8
83741-74-6
mfcd00004413
J-002298
F2191-0105
valeric acid ( pentanoic acid )
valeric acid, analytical standard
valeric acid, pharmaceutical impurity standard
pentanoic acid (valeric acid)
pentanoic acid; valproic acid imp. a (ep); valeric acid; valproic acid impurity a
fa 5:0
1-pentanoate
butanecarboxylate
valeriansaure
valeric acid normal
pentoate
valerianate
1-butanecarboxylate
Q407796
1219804-71-3
HY-N6056
CS-0032261
NCGC00183281-03
pentanoic-3,3-d2 acid
pentanoic-2,2-d2 acid
BS-42203
EN300-19254
pentanoic--d4 acid
valproic acid impurity a (ep impurity)
valeric acid (mart.)
ch3-(ch2)3-cooh
Z104473312

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" To achieve the reutilization of the condensate, the ozonation combined with ion-exchange method was used."( Exploring the resourcing technology of condensate using ozonation combined with ion-exchange in ethanol fermentation.
Li, Z; Sheng, X; Zhang, J, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" There was a striking similarity in the dose-response of butyrate for increasing receptor levels and inhibiting histone deacetylation."( Modulation of thyroid hormone nuclear receptors by short-chain fatty acids in glial C6 cells. Role of histone acetylation.
Aranda, A; Montiel, F; Ortiz-Caro, J; Pascual, A, 1986
)
0.27
" After analyzing dose-response relationship, 300 µM propionic acid or 500 µM valeric acid for 30 min incubation was used for the measurement of glucose uptake."( The effects of propionate and valerate on insulin responsiveness for glucose uptake in 3T3-L1 adipocytes and C2C12 myotubes via G protein-coupled receptor 41.
Han, JH; Jung, SH; Kim, IS; Lee, SG; Myung, CS; Son, HY, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
short-chain fatty acidAn aliphatic monocarboxylic acid with a chain length of less than C6. If any non-hydrocarbon substituent is present, the compound is not normally regarded as a short-chain fatty acid.
straight-chain saturated fatty acidAny saturated fatty acid lacking a side-chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency6.54120.006038.004119,952.5996AID1159523
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency29.26680.001022.650876.6163AID1224838; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency70.08330.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency9.22430.001530.607315,848.9004AID1224841; AID1224848
estrogen nuclear receptor alphaHomo sapiens (human)Potency49.05200.000229.305416,493.5996AID743079
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00120.023723.228263.5986AID743223
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency4.85580.001723.839378.1014AID743083
Guanine nucleotide-binding protein GHomo sapiens (human)Potency0.89131.995325.532750.1187AID624287
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, PROTEIN (5-AMINOLAEVULINIC ACID DEHYDRATASE)Saccharomyces cerevisiae (brewer's yeast)Ki2,000.00002,000.00002,000.00002,000.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (31)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1134606Et2O-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1112932Herbivore repellent activity against adult Arvicola amphibius assessed as time required to enter the test box with apple pieces for first time by T-maze test (Rvb = 240.75 +/-184.07 secs)2013Pest management science, Mar, Volume: 69, Issue:3
The repelling effect of plant secondary metabolites on water voles, Arvicola amphibius.
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1112927Herbivore repellent activity against adult Arvicola amphibius assessed as duration of stay within test box with apple pieces by T-maze test (Rvb = 75.53 +/-16.57%)2013Pest management science, Mar, Volume: 69, Issue:3
The repelling effect of plant secondary metabolites on water voles, Arvicola amphibius.
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1134605Oil-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID447578Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1999Protein science : a publication of the Protein Society, Jun, Volume: 8, Issue:6
The Schiff base complex of yeast 5-aminolaevulinic acid dehydratase with laevulinic acid.
AID1811Experimentally measured binding affinity data derived from PDB1999Protein science : a publication of the Protein Society, Jun, Volume: 8, Issue:6
The Schiff base complex of yeast 5-aminolaevulinic acid dehydratase with laevulinic acid.
AID1345808Human FFA3 receptor (Free fatty acid receptors)2004Proceedings of the National Academy of Sciences of the United States of America, Jan-27, Volume: 101, Issue:4
Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41.
AID1345808Human FFA3 receptor (Free fatty acid receptors)2003The Journal of biological chemistry, Mar-28, Volume: 278, Issue:13
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.
AID1345904Human FFA2 receptor (Free fatty acid receptors)2003The Journal of biological chemistry, Mar-28, Volume: 278, Issue:13
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (219)

TimeframeStudies, This Drug (%)All Drugs %
pre-199043 (19.63)18.7374
1990's31 (14.16)18.2507
2000's41 (18.72)29.6817
2010's72 (32.88)24.3611
2020's32 (14.61)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.87 (24.57)
Research Supply Index5.45 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index99.15 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (59.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (2.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (0.44%)4.05%
Observational0 (0.00%)0.25%
Other218 (96.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]